about us
Zichor Life Tech Pvt. Ltd. was established in 2023 and became operational in August 2025. Founded by a team of three experienced doctors (Dr. Sathya, Dr. Chaitanya and Dr. Swetha). Built with a strong vision of saving lives through advanced medical solutions. Specifically designed to support surgeons, incorporating their practical expertise and clinical insights. Focused on delivering high-quality, reliable, and effective surgical products.
Department Contacts
MEET THE TEAM
Dr. Chaithanya
Managing Director
Dr. Sathyanarayana
Director & CEO
Dr. Swetha
Director & CFO
Rashmi Nair
Chief International Business Officer
S M Narayan
Head of HR
Jayanth Birari
Head of Operation
Raghvendra
Head of Quality
Arun Kumar
Head of Accounts
Rupesh Shimpi
Graphic Designer
Zichor Life Tech Pvt. Ltd. operates on a 3,50,000 sq. ft campus with a 25,000 sq. ft built-up area, featuring an 8,000 sq. ft Class 10,000 (ISO Class 7) clean room & Laminar air ow with Class 100 (ISO Class 5). This controlled environment maintains particle levels below 352,000 particles (≥0.5 µm) per cubic meter, ensuring strict sterility and biocompatibility essential for medical device manufacturing. Our facility is equipped with advanced machinery, in-house laboratory and instrumentation setups, and dedicated R&D units. A team of highly skilled and competent professionals ensures precision, consistency, and uncompromised quality in every product we manufacture.
Our Foundation
BUILT TO LAST
Zichor Life Tech operates from a state-of-the-art biomedical research and manufacturing infrastructure designed to support development, validation, and commercialization of next-generation hemostatic solutions. Our facilities meet the highest international standards combining clean-room manufacturing, advanced analytical laboratories, and dedicated clinical simulation spaces under one roof.
Core Capability
PRECISION AT SCALE
From raw material sourcing to finished product release, every step of our process is governed by a rigorous quality management system. Our infrastructure is built not just to produce but to ensure every unit that leaves our facility performs exactly as designed in the most critical moments a surgeon will face.
01
Clean-Room Manufacturing
ISO Class 7 and 5 certified clean-room environments for contamination controlled production of all hemostatic products and their components.
02
Analytical Laboratories
In-house testing for biocompatibility, sterility, shelf-life, and mechanical performance reducing time from bench to market without compromising rigor.
03
Cold Chain Logistics
End-to-end temperature-controlled distribution infrastructure ensuring product integrity from our facility to the operating room, every time.
04
Digital QMS Platform
Fully digital quality management system covering document control, CAPA, deviation management, change control, and supplier qualification.
ISO
13485 Compliant QMS
Our quality management system is built to ISO 13485 the gold standard for medical device quality assurance globally.
GMP
Manufacturing Standard
All manufacturing processes adhere to Good Manufacturing Practice guidelines as defined by international regulatory authorities.
24/7
Quality Monitoring
Continuous environmental monitoring, automated batch record review, and real-time quality data dashboards always on.
Our R&D pipeline is grounded in a structured, phase-gated development process from in- vitro proof-of-concept through pre-clinical animal models to clinical validation in human surgical cases.
Research Foundation
SCIENCE FIRST
No Zichor product reaches commercialization without rigorous, independent evidence of safety and efficacy. We collaborate with leading academic medical centers, hemostasis research laboratories, and clinical investigators across India and globally to ensure our science is both cutting-edge and clinically relevant. Our development process is physician-led at every stage from identifying unmet clinical need through designing study endpoints that reflect what actually matters to a surgeon at the table under pressure.
Coagulation-Independent Hemostasis
Developing active hemostatic agents that achieve rapid clot formation independently of the patient's own coagulation cascade enabling effective bleeding control in anticoagulated, thrombocytopenic, and coagulopathic patients.
Topical Bioadhesive Hemostats
Engineering next-generation tissue-adhesive hemostatic dressings with superior wet-surface adhesion, biodegradability, and zero foreign-body reaction for both open and laparoscopic applications.
Certification is not a checkbox it is the foundation of our promise to patients, clinicians, and healthcare systems. We pursue the most rigorous international regulatory standards as a reflection of our commitment to safety and quality.
Our Standards
